Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
| Revenue (Most Recent Fiscal Year) | $40.90M |
| Net Income (Most Recent Fiscal Year) | $13.87M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | 13.57 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 4.30 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.55 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.87 |
| Pre-Tax Margin (Trailing 12 Months) | 41.08% |
| Net Margin (Trailing 12 Months) | 33.92% |
| Return on Equity (Trailing 12 Months) | 11.25% |
| Return on Assets (Trailing 12 Months) | 10.72% |
| Current Ratio (Most Recent Fiscal Quarter) | 25.64 |
| Quick Ratio (Most Recent Fiscal Quarter) | 23.29 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.85 |
| Book Value per Share (Most Recent Fiscal Quarter) | $34.62 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $3.95 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 3.28M |
| Free Float | 3.04M |
| Market Capitalization | $175.87M |
| Average Volume (Last 20 Days) | 0.02M |
| Beta (Past 60 Months) | 0.17 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 7.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 69.60% |
| Annual Dividend (Based on Last Quarter) | $1.22 |
| Dividend Yield (Based on Last Quarter) | 2.28% |